MeSH tree: C04.557.450
A new end-to-end PET imaging approach for osteosarcoma can rapidly and reliably distinguish tumor tissue from normal tissue and accurately assess surgical margins in real time. The novel platform, presented at the Society ...
23 hours ago
0
1
Specific genetic fusion patterns in solitary fibrous tumors may help identify which patients face a higher risk of metastasis, recurrence and more aggressive disease behavior, according to new research that could improve ...
May 22, 2026
0
4
A new study has uncovered a genetic cause that may explain why some people develop Kaposi sarcoma despite having no apparent immune deficiency. The rare cancer, which forms in the cells lining blood vessels, is caused by ...
May 14, 2026
0
3
In a breakthrough poised to reshape cancer treatment, Houston Methodist has developed the first personalized mRNA cancer vaccine designed to prevent recurrence of osteosarcoma, a rare and aggressive type of bone cancer. This ...
May 13, 2026
0
15
Rare neuromuscular diseases often lack treatments because developing targeted drugs is slow, costly and risky for companies. A new approach using AI and stem cell models could finally shift the balance.
May 12, 2026
0
4
Leveraging AI capabilities combined with genetic data led St. Jude Children's Research Hospital investigators to predict new cancer drug targets that carry a limited risk of side effects. For their study, published in Science ...
Apr 30, 2026
0
6
Uterine fibroids may be less common in Latina women than earlier estimates suggested, according to new research. The study, led by researchers at Michigan Medicine, is one of the largest in the U.S. to confirm fibroid cases ...
Apr 27, 2026
0
5
Ultrasounds are a critical part of modern health care, helping to image soft tissue and organs, measure blood flow, and monitor fetal development. But the technique has constraints, including a limited field of view and the ...
Apr 24, 2026
0
26
Researchers at the University of British Columbia Faculty of Medicine have developed a new targeted cancer therapy that can precisely seek out and destroy tumor cells—showing strong results in preclinical studies that bring ...
Apr 23, 2026
0
4
Long-term adverse events were rare and manageable among patients with alveolar soft part sarcoma (ASPS), which primarily affects adolescents and young adults, who received immunotherapy beyond the standard two years, according ...
Apr 20, 2026
0
5
